Frederick Nolte to Hepacivirus
This is a "connection" page, showing publications Frederick Nolte has written about Hepacivirus.
Connection Strength
1.210
-
Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent. J Clin Microbiol. 2004 Aug; 42(8):3739-46.
Score: 0.218
-
Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region. J Clin Microbiol. 2003 Apr; 41(4):1558-64.
Score: 0.199
-
Hepatitis C virus genotyping: clinical implications and methods. Mol Diagn. 2001 Dec; 6(4):265-77.
Score: 0.181
-
A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype. Am J Gastroenterol. 2000 Nov; 95(11):3225-9.
Score: 0.168
-
Laboratory diagnosis of hepatitis C. Immunol Invest. 1997 Jan-Feb; 26(1-2):199-207.
Score: 0.129
-
Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA. J Clin Microbiol. 1995 Jul; 33(7):1775-8.
Score: 0.116
-
Isolation of hepatitis C virus RNA from serum for reverse transcription-PCR. J Clin Microbiol. 1994 Feb; 32(2):519-20.
Score: 0.105
-
Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis. 2005 Dec 01; 192(11):1880-9.
Score: 0.059
-
Branched DNA signal amplification for direct quantitation of nucleic acid sequences in clinical specimens. Adv Clin Chem. 1998; 33:201-35.
Score: 0.035